Karyopharm Therapeutics
KPTI
KPTI
86 hedge funds and large institutions have $239M invested in Karyopharm Therapeutics in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $225M → $239M (+$14.5M)
4.12% more ownership
Funds ownership: 0% → 4.12% (+4.1%)
Holders
86
Holding in Top 10
–
Calls
$976K
Puts
$6K
Top Buyers
| 1 | +$13.8M | |
| 2 | +$2.3M | |
| 3 | +$2.15M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.91M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.13M |
Top Sellers
| 1 | -$5.92M | |
| 2 | -$1.51M | |
| 3 | -$433K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$265K |
| 5 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$203K |